Abeona Therapeutics(US:ABEO) Globenewswire·2026-03-03 12:30Core Viewpoint - Abeona Therapeutics Inc. is set to discuss its fourth quarter and full year 2025 financial results and corporate progress in a conference call on March 17, 2026 [1] Group 1: Conference Call Details - The conference call will take place at 8:30 a.m. ET and will be accessible via phone and webcast [1][2] - Participants can join the call by dialing 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) with Entry Code: 977217 [2] - A live webcast and archived replay will be available on the Investors & Media section of Abeona's website for 30 days following the call [2] Group 2: Upcoming Events - Abeona management will participate in a fireside chat at the 2026 Leerink Global Healthcare Conference on March 10, 2026, at 8:40 a.m. ET [3] - The fireside chat will also be available via a live webcast and archived for 30 days on the company's website [3] Group 3: Company Overview - Abeona Therapeutics is a commercial-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [4] - The company's ZEVASKYN is the first autologous cell-based gene therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB) [4] - Abeona operates a fully integrated cGMP manufacturing facility in Cleveland, Ohio, which is used for ZEVASKYN's commercial production [4] - The company is also developing adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical needs [4]